EUVIMEDEUVIMED entdecken
Crossref

A 3‐step method for preparing cryopreserved samples of apheresis products for post‐thaw analysis yields a higher percentage of viable cells

Dustin J Strasburg, Rosalie M Sterner iD, Sildane Va, Eapen K Jacob, Margaret A DiGuardo

Transfusion · 2024

DOI: 10.1111/trf.17822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von Dustin J Strasburg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Cryopreservation, Cell Survival, Flow Cytometry, Blood Component Removal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Standard flow cytometry protocols for CD34+ cell enumeration designed for fresh samples are not appropriate for cryopreserved products. Special protocols have been developed to remove the cryoprotectant by quickly washing a freshly thawed sample. Exposing cells to a large volume of hypotonic solution and subsequent washing process was hypothesized to cause lab‐induced cell death. Moreover, standard gating strategies must be altered to avoid reporting falsely high viabilities. Study Design and Methods We developed a novel method whereby thawed samples were diluted step‐wise to 1:2 by 3 additions of 1/3 sample volume using 1% Human Albumin in Dextran 40 (10% Low Molecular Weight Dextran in 0.9% NaCl) separated by 5 min between each addition. An additional 1:10 dilution was required to obtain a desired cell concentration for flow cytometry testing resulting in a 1:20 dilution.

Results

Twenty samples were tested simultaneously in a method comparison; the new method demonstrated significant increases in mean cell viabilities for white blood cells, hematopoietic progenitor cells, and T cells as well as reduced standard deviations for each parameter.

Discussion

Slow, step‐wise dilutions of freshly thawed samples of cryopreserved apheresis products to 1:20 yielded higher and more precise viability measurements compared to quickly washing samples to remove DMSO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryopreservationCell SurvivalFlow CytometryBlood Component RemovalHumansHematopoietic Stem CellsBlood PreservationCryoprotective AgentsAntigens, CD34

Stichwörter der Autor:innen

CD34HPCcryopreservationpost‐thawviability

Substanzen

Cryoprotective AgentsAntigens, CD34

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Rosalie M Sterner

Zitieren

APA

Strasburg, D. J., Sterner, R. M., Va, S., Jacob, E. K., & DiGuardo, M. A. (2024). A 3‐step method for preparing cryopreserved samples of apheresis products for post‐thaw analysis yields a higher percentage of viable cells. Transfusion. https://doi.org/10.1111/trf.17822

Vancouver

Strasburg DJ, Sterner RM, Va S, Jacob EK, DiGuardo MA. A 3‐step method for preparing cryopreserved samples of apheresis products for post‐thaw analysis yields a higher percentage of viable cells. Transfusion. 2024. doi:10.1111/trf.17822

BibTeX
@article{Strasburg2024,
  author = {Strasburg, Dustin J and Sterner, Rosalie M and Va, Sildane and Jacob, Eapen K and DiGuardo, Margaret A},
  title = {A 3‐step method for preparing cryopreserved samples of apheresis products for post‐thaw analysis yields a higher percentage of viable cells},
  journal = {Transfusion},
  year = {2024},
  doi = {10.1111/trf.17822}
}
Kostenlos starten →